Annemarie M. Rohwer
UCL Great Ormond Street Institute Of Child Health
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Development of the SMA EFFORT: A new approach to characterize perceived physical fatigability in spinal muscular atrophy.
Journal: Journal of neuromuscular diseases
Published: February 20, 2025
Spinal presentations in children with type 1 spinal muscular atrophy on nusinersen treatment across the SMA-REACH UK network: a retrospective national observational study.
Journal: BMJ open
Published: January 22, 2025
Mortality of symptomatic children with spinal muscular atrophy in the era of disease-modifying therapies.
Journal: Neuromuscular disorders : NMD
Published: January 05, 2025
Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale Expanded.
Journal: European journal of neurology
Published: July 17, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module.
Journal: Neuromuscular disorders : NMD
Published: July 11, 2024
Characteristics of Patients With Spinal Muscular Atrophy Who Have Switched Treatments: A Multi-Center Experience in the United Kingdom.
Journal: Muscle & nerve
Published: July 01, 2024
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3.
Journal: Journal of neuromuscular diseases
Published: March 01, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.
Journal: Neuromuscular disorders : NMD
Published: February 21, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
Journal: European journal of neurology
Published: November 06, 2023
Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3.
Journal: Neurology. Clinical practice
Published: October 23, 2023
Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities.
Journal: Journal of clinical medicine
Published: March 30, 2023
Assessment of the upper limb function, strength, and mobility in treatment-naive children with spinal muscular atrophy Types 2 and 3.
Journal: Muscle & nerve
Published: February 01, 2023
Last Updated: 09/26/2026